Condylomata Acuminata

Search with Google Search with Bing
Information
Disease name
Condylomata Acuminata
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT04537156 Active, not recruiting Phase 3 Efficacy, Immunogenicity and Safty Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli) September 5, 2020 December 31, 2027
NCT06297187 Active, not recruiting Cavitronic Ultrasonic Surgical Aspiration (CUSA) Women's Health Study February 23, 2024 August 2024
NCT02710851 Active, not recruiting Phase 2 Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine March 24, 2016 December 30, 2023
NCT05056402 Active, not recruiting Phase 3 An Immuno-bridging Study of a Nonavalent HPV Vaccine (E.Coli) in Healthy Population Aged 9-17 vs Aged 18-26 Years Old September 19, 2021 December 31, 2025
NCT01532102 Completed Phase 1/Phase 2 Safety and Efficacy Study of Topical AP611074 Gel to Treat Genital Warts February 28, 2012 May 6, 2013
NCT01598779 Completed Human Papillomavirus (HPV) Types Present in External Genital Warts (EGW) in the Argentinean Population June 2012 August 2014
NCT01796821 Completed Phase 2 Efficacy and Safety Profiles of SR-T100 Gel on External Genital Warts/Condyloma Acuminate(EGWs) August 2014 October 2018
NCT02015260 Completed Phase 2 A Trial of the Efficacy and Safety of Topical Nitric Oxide in Patients With Anogenital Warts September 2001 May 2003
NCT02405520 Completed Phase 1 Safety and Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine March 26, 2015 May 20, 2022
NCT02535104 Completed Phase 1/Phase 2 Safety and Efficacy Study of Topical Ranpirnase to Treat Genital Warts (HPV) February 2016 September 2016
NCT04782895 Completed Phase 3 Immunogenicity of a Recombinant Human Papillomavirus Nonavalent (Types 6,11,16,18,31,33,45,52,58)Vaccine(E.Coli) Versus Gardasil®9 in Healthy Females 18-26 Years of Age March 14, 2021 July 25, 2022
NCT03546842 Completed Phase 3 Safety and Immunogenicity Study of V503 (GARDASIL™9, 9vHPV Vaccine) Administered to 9- to 26-Year-Old Females and Males in Vietnam (V503-017) June 29, 2018 January 29, 2019
NCT03813940 Completed Phase 1 Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli) January 3, 2019 April 1, 2021
NCT03935204 Completed Phase 2 Immunogenicity Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli) May 13, 2019 April 1, 2021
NCT03981822 Completed Phase 2 A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts June 25, 2019 July 8, 2020
NCT00090285 Completed Phase 3 An Investigational Study of Gardasil™ (qHPV Vaccine) in Reducing the Incidence of Anogenital Warts in Young Men (V501-020) September 3, 2004 April 3, 2017
NCT00449982 Completed Phase 3 Efficacy and Safety Study of Polyphenon E to Treat External Genital Warts July 2003 August 2004
NCT00973856 Completed N/A Evaluation of the Effectiveness of an Alcohol Based Hand Gel for the Reduction of Warts on the Hands September 2009 January 2012
NCT06430190 Not yet recruiting N/A Peginterferon α-2b Combined CO2 Laser in Condylomata Acuminata May 2024 December 2025
NCT06197802 Not yet recruiting Plateau Antibody Levels of a Recombinant (E.Coli) HPV Nonavalent Vaccine Versus Gardasil®9 in Young Women January 10, 2024 December 1, 2024
NCT05087849 Recruiting Phase 1/Phase 2 Intralesional HPV Vaccine for Condylomata April 15, 2022 July 1, 2024
NCT02520986 Recruiting N/A Carbon Dioxide Laser vs. Electrocoagulation for the Therapy of Condyloma December 2016 December 2024
NCT03158974 Terminated Phase 2 A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for the Treatment of External Genital Warts August 1, 2017 June 17, 2018
NCT03853785 Unknown status Phase 3 Efficacy of Intralesional MMR Vaccine,Intralesional Candidal Antigen&Topical Podophyllin in Treatment of Genital Warts February 2020 December 2021
NCT01483794 Unknown status Epidemiology, Costs and Psychosocial Consequences of Genital Warts in Valparaiso, Chile November 2011 April 2012
NCT03158480 Unknown status N/A Safety and Efficacy of Immune Therapy for Condyloma June 25, 2017 June 30, 2019
NCT00365443 Withdrawn Phase 2 Broad Spectrum HPV Vaccine Tolerability, Immunogenicity, and Efficacy Study (V502-003) October 2006
MeSH unique ID (MeSH (Medical Subject Headings))
D003218